Original article by Tamsin Rose, Kieran Rooney
Herald Sun – Page: 11 : 6-Apr-21

The Australian Technical Advisory Group on Immunisation will meet on 7 April to discuss the future rollout of AstraZeneca’s COVID-19 vaccine. A 44-year-old Melbourne man was recently admitted to hospital with a rare blood clotting condition after receiving the vaccine. Acting Chief Medical Officer Michael Kidd says it is "likely" that the case is linked to the vaccine, but he adds that there is no evidence to suggest that the risk is sufficiently high to halt the rollout. Kidd stresses that the vaccination program is necessary as Australia will remain vulnerable to future outbreaks, particularly as its international borders re-open.

CORPORATES
AUSTRALIAN TECHNICAL ADVISORY GROUP ON IMMUNISATION, AUSTRALIA. DEPT OF HEALTH, ASTRAZENECA PLC